Beyond benzodiazepines: a meta-analysis and narrative synthesis of the efficacy and safety of alternative options for alcohol withdrawal syndrome management
ConclusionFor AWS treatments, non-BZDs are superior to or equally effective as BZDs. Non-BZD adverse events warrant further investigation. Agents that inhibit gated ion channels are promising candidates.Protocol registrationPROSPERO CRD42022384875.
Source: European Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Alcoholism | Ativan | Carbamazepine | Drugs & Pharmacology | Gabapentin | International Medicine & Public Health | Lorazepam | Neurontin | Psychiatry | Science | Study